Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: Preliminary results of a randomized, open-labeled, phase II trial
- 1 July 1993
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 26 (4) , 721-729
- https://doi.org/10.1016/0360-3016(93)90299-b
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Blood Transfusion in Patients Receiving Radical Radiotherapy: A ReappraisalOncology Research and Treatment, 1993
- Phase I-II Trial of Erythropoietin in the Treatment of Cisplatin-Associated AnemiaJNCI Journal of the National Cancer Institute, 1992
- Relationship between blood transfusion and tumour behaviourBritish Journal of Surgery, 1991
- PERIOPERATIVE BLOOD TRANSFUSION AND RECURRENCE OF CANCER: IS THERE A DIRECT ASSOCIATION?Anz Journal of Surgery, 1990
- Erythropoietin Treatment of Anemia Associated with Multiple MyelomaNew England Journal of Medicine, 1990
- Decreased Erythropoietin Response in Patients with the Anemia of CancerNew England Journal of Medicine, 1990
- Further Evidence Supporting a Cause and Effect Relationship Between Blood Transfusion and Earlier Cancer RecurrenceAnnals of Surgery, 1988
- Carcinoma of the cervix—anaemia, radiotherapy and hyperbaric oxygenThe British Journal of Radiology, 1983
- EFFECT OF BLOOD TRANSFUSIONS ON COLONIC MALIGNANCY RECURRENCE RATEThe Lancet, 1982
- Improvement of Kidney-Graft Survival with Increased Numbers of Blood TransfusionsNew England Journal of Medicine, 1978